0

Journal Articles

in HIV/AIDS
 1-20 of 220 Articles
Invited Commentary |  April 22, 2013
Getting to the Heart of HIV and Myocardial Infarction:  Comment on “HIV Infection and the Risk of Acute Myocardial Infarction”
Patrick W. G. Mallon, MB, BCh, PhD, FRACP, FRCPI
JAMA Intern Med. 2013;173(8):622-623. doi:10.1001/jamainternmed.2013.264.
Original Investigation |  April 22, 2013
HIV Infection and the Risk of Acute Myocardial Infarction
Matthew S. Freiberg, MD, MSc; Chung-Chou H. Chang, PhD; Lewis H. Kuller, MD, DrPH; et al.
JAMA Intern Med. 2013;173(8):614-622. doi:10.1001/jamainternmed.2013.3728.
INCLUDES: , Supplemental Content
Research Letters |  April 22, 2013 ONLINE FIRST
Extent and Reporting of Patient Nonenrollment in Influential Randomized Clinical Trials, 2002 to 2010
Keith Humphreys, PhD; Natalya C. Maisel, PhD; Janet C. Blodgett, MSc; et al.
JAMA Intern Med. 2013;():1-2. doi:10.1001/jamainternmed.2013.496.
INCLUDES: , Supplemental Content
Editorial |  April 22, 2013 ONLINE FIRST
Trust in the Medical Literature—and Viewpoints in JAMA Internal Medicine
Robert Steinbrook, MD; Rita F. Redberg, MD, MSc
JAMA Intern Med. 2013;():1-2. doi:10.1001/jamainternmed.2013.6281.
Viewpoint |  April 22, 2013 ONLINE FIRST
Improving Health With Partnerships Between Academia and Industry
Susan Desmond-Hellmann, MD, MPH
JAMA Intern Med. 2013;():1-2. doi:10.1001/jamainternmed.2013.826.
Editor's Correspondence |  March 25, 2013
Immunovirologic Control 24 Months After Interruption of Antiretroviral Therapy Initiated Close to HIV Seroconversion
Laurent Hocqueloux, MD; Asier Saez-Cirion, PhD; Christine Rouzioux, PharmD, PhD
JAMA Intern Med. 2013;173(6):475-477. doi:10.1001/jamainternmed.2013.2176.
Editor's Correspondence |  March 25, 2013
Immunovirologic Control 24 Months After Interruption of Antiretroviral Therapy Initiated Close to HIV Seroconversion—Reply
Kholoud Porter, PhD; Sara Lodi, PhD, MSc; Laurence Meyer, MD, PhD
JAMA Intern Med. 2013;173(6):475-477. doi:10.1001/jamainternmed.2013.2784.
Original Investigation |  February 25, 2013
Managed Problem Solving for Antiretroviral Therapy Adherence:  A Randomized Trial
Robert Gross, MD, MSCE; Scarlett L. Bellamy, ScD; Jennifer Chapman, MPH; et al.
JAMA Intern Med. 2013;173(4):300-306. doi:10.1001/jamainternmed.2013.2152.
Invited Commentary |  February 25, 2013
Lifetime HIV Antiretroviral Therapy Adherence Intervention: Timing Is Everything:  Comment on “Managed Problem Solving for Antiretroviral Therapy Adherence”
David R. Bangsberg, MD, MPH; Jessica E. Haberer, MD, MS
JAMA Intern Med. 2013;173(4):306-307. doi:10.1001/jamainternmed.2013.2858.
Research Letters |  February 11, 2013
Opioid Analgesic Misuse in a Community-Based Cohort of HIV-Infected Indigent Adults
Maya Vijayaraghavan, MD, MAS; Joanne Penko, MS, MPH; David R. Bangsberg, MD, MPH; et al.
JAMA Intern Med. 2013;173(3):235-237. doi:10.1001/jamainternmed.2013.1576.
INCLUDES: , Supplemental Content
Editorial |  January 14, 2013 FREE
Controlling HIV/AIDS:  The Obstacles and Opportunities Ahead
Robert Steinbrook, MD
JAMA Intern Med. 2013;173(1):11-12. doi:10.1001/2013.jamainternmed.874.
Invited Commentary |  November 12, 2012
HIV Racial Disparities:  Comment on “The Influence of Sex, Race/Ethnicity, and Educational Attainment on Human Immunodeficiency Virus Death Rates Among Adults, 1993-2007”
William Cunningham, MD, MPH
Arch Intern Med. 2012;172(20):1599-1600. doi:10.1001/2013.jamainternmed.613.
Original Investigation |  November 12, 2012
The Influence of Sex, Race/Ethnicity, and Educational Attainment on Human Immunodeficiency Virus Death Rates Among Adults, 1993-2007
Edgar P. Simard, PhD, MPH; Mesfin Fransua, MD; Deepa Naishadham, MA, MS; et al.
Arch Intern Med. 2012;172(20):1591-1598. doi:10.1001/archinternmed.2012.4508.
INCLUDES: , Supplemental Content
Original Investigation |  September 24, 2012
Choice of Initial Combination Antiretroviral Therapy in Individuals With HIV Infection:  Determinants and Outcomes
Luigia Elzi, MD, MSc; Stefan Erb, MD; Hansjakob Furrer, MD; et al.
Arch Intern Med. 2012;172(17):1313-1321. doi:10.1001/archinternmed.2012.3216.
Invited Commentary |  September 24, 2012
An Abundance of Choices:  Comment on “Choice of Initial Combination Antiretroviral Therapy in Individuals With HIV Infection: Determinants and Outcomes”
Daniel R. Kuritzkes, MD
Arch Intern Med. 2012;172(17):1321-1323. doi:10.1001/archinternmed.2012.3644.
Original Investigation |  September 10, 2012
Effect of Early Syphilis Infection on Plasma Viral Load and CD4 Cell Count in Human Immunodeficiency Virus–Infected Men:  Results From the FHDH-ANRS CO4 Cohort
Witold Jarzebowski, MD, MSc; Eric Caumes, MD; Nicolas Dupin, MD; et al.
Arch Intern Med. 2012;172(16):1237-1243. doi:10.1001/archinternmed.2012.2706.
INCLUDES: , Supplemental Content
Brief Report |  September 10, 2012
Immunovirologic Control 24 Months After Interruption of Antiretroviral Therapy Initiated Close to HIV Seroconversion
Sara Lodi, PhD, MSc; Laurence Meyer, MD, PhD; Anthony D. Kelleher, PhD, MB; et al.
Arch Intern Med. 2012;172(16):1252-1255. doi:10.1001/archinternmed.2012.2719.
Invited Commentary |  September 10, 2012
Prevention, Detection, and Treatment of Coinfections: A Priority in Human Immunodeficiency Virus–Infected Persons to Reduce Viral Load and Consequent Disease Progression and Transmission :  Comment on “Effect of Early Syphilis Infection on Plasma Viral Load and CD4 Cell Count in Human Immunodeficiency Virus–Infected Men”
Sten H. Vermund, MD, PhD
Arch Intern Med. 2012;172(16):1243-1244. doi:10.1001/archinternmed.2012.3770.
Research Letters |  July 09, 2012
Safety Against Cervical Precancer and Cancer Following Negative Human Papillomavirus and Papanicolaou Test Results in Human Immunodeficiency Virus–Infected Women
Philip E. Castle, PhD, MPH; Barbara Fetterman, SCT(ASCP); Nancy Poitras, PMP; et al.
Arch Intern Med. 2012;172(13):1041-1043. doi:10.1001/archinternmed.2012.1744.
Editor's Correspondence |  March 26, 2012
Nontargeted HIV Screening in Emergency Departments
Leonard Anang Sowah, MBChB, MPH; Ashley Nicole Rock, RN, MS, MBA; Anthony Amoroso, MD
Arch Intern Med. 2012;172(6):522-523. doi:10.1001/archinternmed.2011.1888.

Sign In

Register for a FREE personal account

and access these and other features:

Register Now

Want to Subscribe?

Learn More about subscription options.

Don't have Access?

Register and get free email Table of Contents alerts, saved searches, PowerPoint downloads, CME quizzes, and more

Subscribe for full-text access to content from 1998 forward and a host of useful features

Activate your current subscription (AMA members and current subscribers)

From The JAMA Network
JAMA
Original Contribution  |  May 01, 2013
Association Between Efavirenz-Based Compared With Nevirapine-Based Antiretroviral Regimens and Virological Failure in HIV-Infected Children
Elizabeth D. Lowenthal, MD, MSCE; Jonas H. Ellenberg, PhD; Edwin Machine, MPH; et al.
JAMA Ophthalmology
Clinical Sciences  |  March 14, 2013
Clinical Manifestations of Cytomegalovirus-Associated Posterior Uveitis and Panuveitis in Patients Without Human Immunodeficiency Virus Infection
Kessara Pathanapitoon, MD, PhD; Nattaporn Tesavibul, MD; Pitipol Choopong, MD; et al.
JAMA
Medical News and Perspectives  |  April 24, 2013
IOM Report Advises Shift in Focus for Next Phase of US AIDS Relief Program
Anita Slomski
JAMA
From the Centers for Disease Control and Prevention  |  April 24, 2013
QuickStats: Human Immunodeficiency Virus (HIV) Disease Death Rates Among Men Aged 25-54 Years, by Race and Age Group—National Vital Statistics System, United States, 2000—2010
© 2013 American Medical Association. All Rights Reserved.
Powered bySilverchair Information Systems